CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 50 enrolled
Drug / intervention
Normal Saline +1 moredrug
Likely dose
Hydrocortisone 100mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00676585
NCT00676585Phase 2Completed
CompareCT.gov

Corticosteroids Therapy in Refractory Shock Following Cardiac Arrest

Beth Israel Deaconess Medical Center·interventional·Posted May 13, 2008·Updated May 17, 2017

In Brief

A Phase 2 clinical trial evaluating Normal Saline and Hydrocortisone for Cardiac Arrest. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The major goal of this project is to determine whether the use of physiologic doses of corticosteroids will decrease time to shock reversal, alters the inflammatory cascade, and alters microcirculatory flow in post-cardiac arrest patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Arrest
CountriesUnited States
CollaboratorsAmerican Heart Association

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 13, 2008
Enrollment StartOct 1, 2007
Primary CompletionApr 1, 2014
TodayJul 2, 2026
Enrollment to primary: 6.5 yearsPosted 18.1 years ago

Interventions

Normal Salinedrug

Normal Saline

Hydrocortisonedrug

Hydrocortisone 100mg